Tourmaline Bio Inc (TRML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -73,210 | -42,124 | -19,701 | -47,833 | -22,707 |
| Depreciation Amortization | -7,555 | -489 | 6 | 1,050 | 542 |
| Accounts payable and accrued liabilities | 2,437 | -44 | 193 | 1,323 | 100 |
| Other Working Capital | -3,154 | -168 | 902 | 2,315 | 1,614 |
| Other Operating Activity | 4,219 | 14,744 | 12,142 | 3,157 | 1,239 |
| Operating Cash Flow | $-77,263 | $-28,081 | $-6,458 | $-39,988 | $-19,212 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -56 | -68 | -2,437 | -1,286 |
| Net Acquisitions | N/A | N/A | -5,000 | N/A | N/A |
| Purchase Of Investment | -366,136 | -16,604 | N/A | -275,879 | -158,237 |
| Sale Of Investment | 171,840 | 20,500 | N/A | 181,929 | 26,224 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1 |
| Investing Cash Flow | $-194,305 | $3,840 | $-5,068 | $-96,387 | $-133,300 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 250 | N/A | N/A |
| Debt Repayment | N/A | N/A | -400 | N/A | N/A |
| Common Stock Issued | 161,352 | 144 | N/A | 140,046 | 1,649 |
| Common Stock Repurchased | -4 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 156,576 | 20,000 | -2,646 | 129,474 |
| Financing Cash Flow | $161,348 | $156,720 | $19,850 | $137,400 | $131,123 |
| Beginning Cash Position | 140,953 | 8,474 | 150 | 17,589 | 38,978 |
| End Cash Position | 30,733 | 140,953 | 8,474 | 18,614 | 17,589 |
| Net Cash Flow | $-110,220 | $132,479 | $8,324 | $1,025 | $-21,389 |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,263 | -28,081 | -6,458 | -39,988 | -19,212 |
| Capital Expenditure | -9 | -56 | -68 | -2,437 | -1,286 |
| Free Cash Flow | -77,272 | -28,137 | -6,526 | -42,425 | -20,498 |